CHELMSFORD, Mass.–(BUSINESS WIRE)– #ZOLLMedical–ZOLL(R) Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has acquired Respicardia, Inc., a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA). CSA is a serious condition that is often associated with heart failure, coronary artery disease, and certain cardiac arrhythmias. Respicardia’s remede(R) System is a revolutiona